Filing Details
- Accession Number:
- 0001237899-12-000018
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-02-02 16:44:46
- Reporting Period:
- 2012-01-31
- Filing Date:
- 2012-02-02
- Accepted Time:
- 2012-02-02 16:44:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226435 | A Murray Goldberg | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Finance And Admin Cfo Trea | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-01-26 | 2,250 | $0.00 | 87,111 | No | 5 | G | Direct | |
| Common Stock | Acquisiton | 2012-01-31 | 28,079 | $20.32 | 115,190 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-01-31 | 6,334 | $90.07 | 108,856 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2012-01-31 | 10,017 | $90.07 | 98,839 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2012-01-31 | 16,000 | $21.92 | 114,839 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2012-01-31 | 3,893 | $90.07 | 110,946 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2012-01-31 | 5,577 | $90.07 | 105,369 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2012-02-01 | 3,015 | $90.64 | 102,354 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-02-01 | 7,151 | $91.71 | 95,203 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-02-01 | 7,992 | $92.22 | 87,211 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-02-01 | 100 | $93.04 | 87,111 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 5 | G | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-01-31 | 28,079 | $0.00 | 28,079 | $20.32 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2012-01-31 | 16,000 | $0.00 | 16,000 | $21.92 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2012-01-31 | 6,334 | $0.00 | 6,334 | $90.07 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Acquisiton | 2012-01-31 | 3,893 | $0.00 | 3,893 | $90.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 1,200 | 2016-12-18 | No | 4 | M | Direct | |
| 54,438 | 2017-12-17 | No | 4 | M | Direct | |
| 6,334 | 2012-01-31 | 2016-12-18 | No | 4 | A | Direct |
| 3,893 | 2012-01-31 | 2017-12-17 | No | 4 | A | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,416 | Indirect | By 401(k) Plan |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 3,015 shares of Company stock on February 1, 2012 at prices ranging from $90.06 to $90.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2012 at each separate price.
- Represents volume-weighted average price of sales of 7,151 shares of Company stock on February 1, 2012 at prices ranging from $91.00 to $91.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2012 at each separate price.
- Represents volume-weighted average price of sales of 7,992 shares of Company stock on February 1, 2012 at prices ranging from $92.00 to $92.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 1, 2012 at each separate price.
- The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
- Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
Billionaire Hedge Funds
